Manufacturer
15 recalls in our database name Boehringer Ingelheim Roxane Inc as the manufacturing or recalling firm.
Of the 15 recalls from Boehringer Ingelheim Roxane Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (7%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Boehringer Ingelheim Roxane Inc. is recalling furosemide tablets USP because the wrong active pharmaceutical ingredient was used during manufacturing.
Boehringer Ingelheim Roxane Inc. is recalling 5,160 bottles of Furosemide Tablets USP because the wrong active ingredient was used during manufacturing.
Boehringer Ingelheim is recalling 358,647 Combivent Respimat inhalers because the delivery system may fail to spray properly.
Boehringer Ingelheim Roxane Inc is recalling Acarbose 50 mg tablets because potency was below specification at a 9-month stability time point.
Boehringer Ingelheim Roxane Inc is recalling 2,149 vials of Oxycodone Hydrochloride Oral Solution due to out-of-specification preservative levels.
Boehringer Ingelheim Roxane Inc. is recalling 5,364 bottles of Calcitriol Oral Solution 1 mcg/mL due to a failed impurity specification.
Boehringer Ingelheim Roxane Inc is recalling 8,304 bottles of Azathioprine Tablets USP, 50 mg, because they were labeled with 36-month expiration dates instead of the approved 24 months.
Boehringer Ingelheim Roxane Inc. is recalling Mercaptopurine Tablets USP because they were labeled with 36-month expiration dates instead of the approved 24 months.
Boehringer Ingelheim is recalling Spiriva HandiHaler capsules because a defective delivery system may cause dose delivery out of specification.
Boehringer Ingelheim Roxane Inc. is recalling Oxcarbazepine Tablets, 150 mg, due to out-of-specification assay results and potential lower weight tablets.
Boehringer Ingelheim is recalling 10,267 bottles of Oxcarbazepine Oral Suspension because the product failed to meet resuspendability requirements.
Boehringer Ingelheim is recalling SPIRIVA HandiHaler capsules due to potential foreign particles in the active pharmaceutical ingredient.
Boehringer Ingelheim Roxane Inc is recalling 14,619 cartons of Prednisone 20 mg tablets because the blister cards are missing labels.
Boehringer Ingelheim Roxane Inc. is recalling 3,553 bottles of Perindopril Erbumine Tablets, 8mg, because out-of-specification results were found for impurity B.
Boehringer Ingelheim is recalling 8,381 bottles of Pradaxa 75 mg capsules because defective containers may allow moisture to enter, potentially impairing product quality.